Heparan sulphate is one of the candidate receptors for hepatitis C virus (HCV). Envelope glycoproteins of HCV have been proposed to be responsible for recognition and binding with cell receptors. They are characterized by great genetic polymorphism. In this study the mapping of regions with glycosaminoglycan-binding properties within HCV envelope proteins has been undertaken. We prepared a set of overlapping peptides corresponding to conserved regions of these envelope proteins and analysed them by solid phase heparin-binding assay. The search for established glycosaminoglycan-binding motifs in the HCV envelope proteins showed the absence of the sites corresponding to the glycosaminoglycan-binding patterns in consensus sequence. We identified one highly conserved and two less conserved heparin-binding sequences within the envelope protein E2 based on solid phase assay results. We did not find any differences in binding efficiency of these peptides with heparin, heparan sulphate or dextran sulphate. Our data supported the specific association between HCV envelope protein E2 and cell surface glycosaminoglycans. We hypothesize that identified regions from E2 can contribute to HCV binding to cell surface glycosaminoglycans.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2893.2005.00647.xDOI Listing

Publication Analysis

Top Keywords

hcv envelope
16
envelope proteins
12
hepatitis virus
8
heparan sulphate
8
binding cell
8
solid phase
8
envelope protein
8
cell surface
8
surface glycosaminoglycans
8
envelope
7

Similar Publications

Hepatitis C virus (HCV) is a major public health concern, and the development of an effective HCV vaccine plays an important role in the effort to prevent new infections. Supramolecular co-assembly and co-presentation of the HCV envelope E1E2 heterodimer complex and core protein presents an attractive vaccine design strategy for achieving effective humoral and cellular immunity. With this objective, the two antigens were non-covalently assembled with an immunostimulant (TLR 7/8 agonist) into virus-mimicking polymer nanocomplexes (VMPNs) using a biodegradable synthetic polyphosphazene delivery vehicle.

View Article and Find Full Text PDF

Background: Egypt has the highest global prevalence of Hepatitis C Virus (HCV) infection, particularly of genotype 4. The development of a prophylactic vaccine remains crucial for HCV eradication, yet no such vaccine currently exists due to the vaccine development challenges. The ability of Virus-Like Particles (VLPs) to mimic the native virus and incorporate neutralizing and conformational epitopes, while effectively engaging both humoral and cellular immune responses, makes them a promising approach to addressing the challenges in HCV vaccine development.

View Article and Find Full Text PDF

Hepatitis C virus (HCV) infection causes ~290,000 annual human deaths despite the highly effective antiviral treatment available. Several viral immune evasion mechanisms have hampered the development of an effective vaccine against HCV, among them the remarkable conformational flexibility within neutralization epitopes in the HCV antigens. Here, we report the design of epitope-focused immunogens displaying two distinct HCV cross-neutralization epitopes.

View Article and Find Full Text PDF

Hepatitis C virus (HCV) is a major human pathogen causing liver diseases. Although direct-acting antiviral agents effectively inhibit HCV infection, cell-cell transmission remains a critical venue for HCV persistence in vivo. However, the underlying mechanism of how HCV spreads intercellularly remains elusive.

View Article and Find Full Text PDF
Article Synopsis
  • - The development of a vaccine for Hepatitis C Virus (HCV) is essential despite the effectiveness of existing treatments, particularly focusing on inducing Pangenomic neutralizing Antibodies (PnAbs) against the diverse HCV Envelope 2 protein.
  • - Current algorithms for creating Consensus Sequences (CS) face challenges such as rigidity and insensitivity to evolutionary changes, prompting researchers to modify the "Majority" algorithm with BLOSUM matrices and assess it against the "Fitness" algorithm.
  • - The "Fitness" algorithm outperformed others by producing well-defined HCVE2 sequences for all HCV genotypes, considering evolutionary factors and offering improved properties for vaccine development, suggesting its applicability for other variable pathogens as well. *
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!